The role of cell surface immunoglobulin in helper T-cell-dependent B-cell activation was analyzed using a B-cell lymphoma, CH12, with known antigen specificity and activation properties similar to those of a resting B cell. Two sources of helper T cells were used, both selected such that they interact with H-2-encoded determinants on CH12 in the absence of the specific B-cell antigen, sheep erythrocytes. By this dissociation of the specificity of the T cells from that of the B cells, the requirement for antigen in the induction of CH12 to antibody secretion could be studied. The results show that both helper T-cell-B-cell interactions and surface immunoglobulin-antigen binding are involved in inducing B-cell differentiation, thus establishing a signalling function for the antigen receptor on B lymphocytes. Our data also show that the requirement for surface immunoglobulin-ligand interactions in B-cell activation can, under certain conditions, be circumvented, notably when high (nonphysiologic) multiplicities of Tcell help are used.
The binding of antigen to surface immunoglobulin (sIg) on the B-cell membrane facilitates the interaction of antigenspecific helper T (Th) cells with specific B cells by "bridging" the two cell types. Whether the function of the sIg molecule is to passively focus T-cell help onto the B-cell membrane (1) or whether the binding of antigen to sIg also fulfills a signalling function (2) has been a matter of contention. Resolution of this controversy requires that the Th-cell and Bcell specificities for antigen be dissociated, and T-cell specificity must be selected such that efficient T-B interaction occurs independently of the involvement of sIg. Such a method is suggested by the work of Augustin and Coutinho (3) , who demonstrated that T cells specific for minor histocompatibility antigens (distinct from slg) on the B-cell surface can polyclonally stimulate B cells. Using this approach, Martinez-A and Coutinho (4) have found data that they interpret as evidence that direct T-cell-B-cell interactions are necessary and sufficient for B-cell activation to antibody secretion. Similar studies by Julius et al. (5) have led to a different conclusion. Direct Th-cell-B-cell interactions were found to be ineffective in stimulating B cells to antibody secretion unless a "second signal," provided by anti-Ig antiserum, was also provided.
A definitive answer regarding the function of sIg is essential to further analysis of the molecular events that are involved in B-cell activation. However, because of the significant differences in the activation properties of resting B cells compared with nonresting B cells (5) (6) (7) (8) (9) , this question can be resolved only by using a uniform source of resting B cells. To this end, we have taken advantage of a unique antigen (sheep erythrocyte, SRBC)-specific B-cell lymphoma, CH12 (10) , that has the activation properties of a resting B cell (11) . We report here our results showing conclusively that sIg-ligand interactions transmit a signal that contributes to B-cell activation.
MATERIALS AND METHODS Animals. B10.H-2aH-4bp/Wts (2a4b) mice were bred and maintained under pathogen-free conditions at the University of North Carolina. (BALB/c x C57BL/6)F1 (CB6F1, H-2d/b), BALB/c (C, H-2d), and C3H/HeJ (C3H, H-2) mice were purchased from The Jackson Laboratory and maintained in the animal colony at Duke University. All mice were 8-to 12-wk old when used.
CH12 Lymphoma Cells. CH12 arose in a 2a4b mouse and was propagated as an ascites tumor. The induction, characterization, and identification of the tumor cells' specificity for SRBC have been described (10) . From the ascites, 94.3 + 5.5% of the cells were ,u by immunofluorescence (10 experiments) while 1.2 ± 0.4% were nonspecific esterase positive (four determinations). The role, if any, that these latter cells in the tumor preparation might play in the activation of CH12 has not been analyzed. In 8 experiments, 89.9 ± 6.4% of the cells rosetted with SRBC but none with human erythrocytes or mouse erythrocytes (MRBC). We have recently found that this apparent specificity for SRBC is likely to be a cross-reaction with autologous effete erythrocytes, because CH12 rosettes as efficiently with bromelain-treated MRBC (12) as with SRBC. Greater than 95% of cells are positive for the CH12 idiotype, as determined using a specific rabbit anti-idiotypic antiserum (C. A. Pennell, personal communication). The lymphoma cells express both I-Ak and I-Ek molecules (13) . The cell-dependent activation of CH12 can be achieved in the presence of H-2' (I-Ek)-restricted SRBC-specific Th cells and the specific antigen, SRBC. The requirement for specific antigen and H-2-restricted Th cells for activation, as displayed by CH12 (11) , is a property of resting B cells (5) (6) (7) (8) (9) . Like resting B cells (5, 6) , CH12 can also be stimulated with lipopolysaccharide; antigen is not required for lipopolysaccharide-induced differentiation (ref. 5 ; see also Table 2 ). For simplicity, we refer to the CH12 lymphoma as a "resting" B-cell population. It should be pointed out, however, that this analogy is made only with respect to the properties described above. Clearly, CH12 cells are proliferating, and other differences may yet be found.
As with other tumor cell model systems, only a small fraction of CH12 cells (usually <10%) are normally induced to secrete antibody. It is unlikely that this is due to insensitivity of the plaque assay, because in control experiments the number of plaque-forming cells (pfc) measured by direct and reverse plaque assays were similar. It is possible that differen-tiation to antibody secretion is an end stage in the development of CH12 and that the inability to induce a larger fraction of cells to secrete is related to their proliferative phenotype.
Helper T-Cell Lines. Two types of Th-cell lines have been used. Alloreactive Th-cell lines specific for H-2k (CB6F1 anti-C3H) or H-2b (C anti-B6) were prepared as described (14, 15) . Greater than 95% of these cells are Thyl and 0.5-1% have the properties of macrophages (15) . Keyhole limpet hemocyanin (KLH)-specific T-cell lines established from 2a4b or CB6F1 mice were prepared using a previously described method (15) . The CB6F1 Th cell lines are devoid of alloreactivity for H-2a-encoded alloantigens (16) . These Th lines have been used in T-cell-B-cell systems in which requirements for Th-cell activation are different from those for activation of resting B cells (8, 16) . The Th cells obtained are contaminated with few macrophages (16) .
Helper Assays and Enumeration of Antibody Secreting Cells. Cells were cultured in 16-mm-diameter multiwell dishes in 2 ml of RPMI 1640 supplemented with 10% fetal bovine serum, 2 mM L-glutamine, gentamycin (50 pug/ml), and 50 ,RM 2-mercaptoethanol. Cultures contained 2 x 105 CH12 cells, SRBC or MRBC (1 x 106/ml), and various numbers of allospecific or KLH-specific Th cells. In cultures of CH12 and KLH-specific Th cells, KLH was added at various concentrations as a T-cell stimulus. Th cells were irradiated (1400 rads; 1 rad = 0.01 gray) before use in all experiments. After 3 or 4 days of culture, CH12 cells remaining were counted and plaque assays were carried out on SRBC monolayers using the method of Cunningham and Szenberg (17) .
Measurement of Interleukin 2 (IL-2). Supernatants were collected 48-64 hr after initiation of culture and the presence of IL-2 was assayed by the ability of supernatants to support the growth of IL-2-dependent T-cell blasts (16) . The results were quantitated and expressed as units, where a standard source of IL-2-containing conditioned medium from mitogen-stimulated spleen cells was considered to possess 100 units/ml of IL-2 activity (18).
RESULTS
Differentiation of CH12 Induced by Alloreactive Th Cells. CH12 lymphoma cells and irradiated alloreactive (CB6F1 anti-C3H) Th cells were incubated together with or without SRBC. Such alloreactive T-cell populations are capable of polyclonal stimulation of B cells (3, 19) . As such, they interact with antigens on the B-cell surface regardless of B-cell specificity and irrespective of the presence of specific B-cell antigen (3) (4) (5) . After 4 days, the number of pfc generated in the cultures was determined. The most striking result was the effect of the specific B-cell antigen SRBC ( Fig. 1 ). At all concentrations greater than 500 allospecific Th cells per culture, the number of anti-SRBC pfc generated was significantly higher when the antigen SRBC was added. In cultures containing 5 x 103 and 5 x 104 T cells, induced differentiation of CH12 was observed only in the presence of SRBC. SRBC alone had no effect. The number of pfc detected was increased when expressed on a viable recovered CH12 cell basis as well as on a per culture basis, establishing that this increase is due to the differentiation of CH12 rather than to a selective proliferation of tumor cells in cultures containing T cells or SRBC. Only 1% as many T cells were required in cultures containing SRBC than in cultures lacking SRBC for equivalent numbers of pfc to be generated. It is noteworthy that, in the absence of SRBC, the number of pfc generated in cultures containing 5 x 105 T cells was significantly elevated ( Fig. 1 ).
Differentiation of CH12 Induced by KLH-Specific Th Cells. KLH-specific Th cells from 2a4b mice were added to cultures containing CH12 cells and various concentrations of KLH. Cultures also contained the specific B-cell antigen SRBC or, as controls, MRBC or no erythrocytes. After 4 days, pfc were enumerated (Fig. 2 ). The addition of SRBC to cultures containing Th cells, KLH, and CH12 cells increased the number of pfc generated up to 10-fold compared with control cultures. Significant stimulation of CH12 above background was observed only in those cultures receiving higher concentrations of the specific T-cell antigen, KLH (>10 pug/ml). The number of SRBC-specific pfc generated was also dependent on the number of KLH-specific Th cells added (data not shown). In other experiments we tested whether Th-cell activation occurred in cultures containing CH12 and KLH, but lacking SRBC, by assaying for the production of various Th-cell-derived lymphokines, including IL-2 and those factors active in a T-cell-replacing factor assay. We found no difference in the levels of nonspecific factors in supernatants from cultures containing SRBC and from those lacking SRBC. Therefore, any differences in the activation of CH12 to antibody secretion between cultures containing the specific B-cell antigen and those without it reflects the activation requirements of the B cells and not of the KLH-specific Th cells. We next addressed the question of whether H-2-specific interactions between Th cells and CH12 are required for CH12 to be induced to differentiate. In the first experiment, the capacity of KLH-specific Th cells from CB6F1 mice to induce CH12 was compared with that of Th cells from 2a4b mice. As shown in Table 1 , only the H-2a-restricted Th cells were effective. This was the case even though conditions were sufficient to allow for the activation of both Th-cell populations, as shown by the antigen (KLH)-dependent production of IL-2 in these cultures. This result was not unexpected because, as is well established, H-2-restricted interactions with Th cells are required for the activation of normal resting B cells (5-9) and for CH12 lymphoma cells (11) . As shown in Table 1 , only cultures receiving both SRBC and KLH gave maximal numbers of pfc, although more response was observed in the presence of KLH alone.
In the second experiment, alloantigen-reactive Th cells specific for H-2b-encoded determinants not expressed on CH12 were tested for ability to induce antibody secretion. As shown in Table 2 , these T cells were ineffective in stimulating CH12 cells, even though a source of stimulator cells from H-2b mice was included in cultures to ensure Th-cell activation. This result contrasts with that obtained using alloantigen-reactive Th cells specific for determinants on the CH12 lymphoma (Fig. 1) . For the experiment presented in Table 2 , two controls were carried out to ensure that the Th cells were active. First, supernatants from cultures of CH12 and H-2b-specific Th cells were assayed for IL-2. When irradiated stimulator cells were included with Th cells in the cultures, IL-2 was detected in the supernatants. Although the amount of IL-2 was generally low (<20 units per culture), substantial amounts were found in some of the culture supernatants (>100 units per culture). As expected, the level of IL-2 was not dependent on the presence of SRBC (see also Table 1 ). In the second experiment, helper function of the alloreactive T cells was tested by measuring their ability to induce SRBC-specific responses from B6 B cells (15) . As *T-depleted (anti-Thy-1.2/complement) B6 spleen cells were added to culture under conditions of limiting dilution and stimulated with various numbers of allospecific T cells and SRBC as described (15) . Production of anti-SRBC antibody was determined by the spot test and frequencies of inducible precursors were determined by Poisson analysis (15) . Each data point represents 48 replicate values.
shown in Table 2 , similar frequencies of SRBC-specific precursors were activated over a wide range of H-2b-specific T cells, showing that the failure to induce CH12 to antibody secretion was not a result of the lack of competent helper cells in the alloreactive population. Taken together, the results show that activation of Th cells alone is insufficient for the activation of CH12 and that a direct interaction between Th cells and H-2-encoded determinants on CH12 cells is required for B-cell activation to occur.
DISCUSSION
Our results provide direct and definitive evidence that the slg molecule plays an active role in B-cell activation. Although two distinct types of Th-cell lines were used, the results were the same: induction of CH12 to antibody secretion was always enhanced when the B-cell antigen SRBC was included in the culture. The activation of the Th cells occurred in the absence of SRBC. Thus, the differences measured were a direct reflection of the effect of SRBC on the induction of CH12 cells and, as a result, show that slg-ligand interactions have a signalling function in B-cell activation.
Whether the slg molecule performs this function only in the early stages of B-cell activation or is required intermittently throughout the course of B cell responses remains to be determined.
Clearly, the binding of antigen to slg molecules is not an absolute prerequisite for B-cell activation. Polyclonal B-cell activators function in the absence of slg-antigen interactions, and at least one of these, lipopolysaccharide, can activate normal resting B cells (5, 6, 20) as well as CH12 cells (ref. 11; Table 2 ) in the absence of specific antigen. Under certain conditions, Th cells can also activate resting B cells in the absence of the binding of specific antigen to slg molecules. Using alloreactive T-cell help, we found that high Tcell/B-cell ratios led to limited B-cell activation without the B-cell-specific antigen present (Fig. 1 ). This observation may account, at least in part, for the differences between the results of Martinez-A and Coutinho (4) and of Julius et al. (5) . In the present study, we observed a limited degree of activation of CH12 in the absence of SRBC using KLH-specific Th cells (Fig. 2 and Table 1 ). High concentrations of protein antigens, such as KLH, may serve to focus higher numbers of Th cells onto the B-cell surface, leading to activation of the B cells in the absence of specific B-cell antigen. Alternatively, processing of high concentrations of protein antigens by resting B cells may lead to nonspecific modulation of sIg molecules, as suggested (7), mimicking the effects of polyvalent sIg-ligand interactions. Whatever the mechanism, these high levels of Th-cell multiplicity and/or antigen concentrations are unlikely to be achieved in vivo. Thus, the ability to trigger B cells when specific antigen binding has been circumvented does not argue against an active (signalling) role of sIg molecules in B-cell activation under physiologic conditions. CH12 could be activated only if the Th cells used were restricted by (Table 1 ) or specific for ( Table 2 ) H-2-encoded determinants on the CH12 surface. Because the activation of Th cells was necessary but insufficient for B-cell activation, these results suggest that direct T-cell-B-cell interactions are required for the stimulation of CH12. Several possible explanations could account for these observations. First, they could indicate a requirement to focus Th cells into close proximity of the B-cell membrane, leading to an increase in the local concentration of Th-cell-derived factors. Although we cannot rule this possibility out, it is unlikely because CH12 is refractory to the effects of nonspecific factors (Tables 1 and 2; ref. 11). We favor an alternative explanationnamely, that the requirement for direct interactions between Th cells and B cells reflects a signalling function of major histocompatibility complex-encoded class II (Ia) molecules on the B cell membrane. Thus, the interaction of Th cells with B-cell Ta would provide a requisite transmembrane signal to the B cell. Whether this signal could be provided by both major histocompatibility complex-restricted Th factors (21) and the T-cell receptor itself is open to speculation.
Our data show that linked interactions between Th cells and B cells with specificity for epitopes on the same antigen molecule are not required for B-cell triggering to occur. Although specific induction of Th cells and direct Th-cell-Bcell interactions are prerequisites for the activation of resting B cells, antigen-specific T-cell help is not a requirement, in the sense implied by the recognition of determinants on a single molecular complex by the responding lymphocytes. This indicates that the B cell can be activated following the independent binding of antigen to sIg molecules and the interaction of Th cells with H-2-encoded Ta molecules. This does not necessarily mean these two events can be separated in time. First, although the binding of "T-dependent" antigens to normal B cells may cause some of the changes characteristic of early events in B-cell activation, entry into the cell cycle does not occur (22) nor do changes in the subsequent B-cell-response patterns (8) . In preliminary experiments, we have found that the addition of either SRBC or KLH-specific Th cells (and KLH) to CH12 1 day prior to addition of the other does not alter the time course of the antibody response, suggesting that differentiation begins only when both interactive events have occurred.
The CH12 lymphoma will be made available as an ascites tumor to investigators who request it. We are currently adapting CH12 to in vitro culture. Once a stable clone is es-tablished, we will make it available through the American Type Culture Collection, Rockville, MD.
